Anti-Tumor Activity of Cdk2/9 Inhibitor Fadraciclib in an In Vivo Model of Temozolomide Refractory Neuroblastoma.

fadraciclib (CYC065) - Bio Green Med Solution

temozolomide - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/42338302

Barbara Martins da Costa; Charles Y Lin; Evon Poon; Giuseppe Barone; Karen T Barker; Kevin Greenslade; Konstantinos Zormpas-Petridis; Louis Chesler; Paul Workman; Qiong Gao; Quinty Vellema; Simon P Robinson; Tong Liang; Yann Jamin

Jun 25, 2026